After Coronary Stents, Regulator Caps Prices Of Knee Implants
India's drug pricing regulator has capped the prices of knee implants to control “excessive trade margins” in public interest, nearly six months after it brought coronary stents under price control.
The National Pharmaceutical Pricing Authority fixed the cost of a primary knee replacement implant between Rs 4,000 and Rs 38,740, according to a list notified by the regulator. Earlier, the prices could go up to Rs 9 lakh, it said.
NPPA fixes the ceiling prices of knee implants in follow up to Honourable PM's declaration https://t.co/6eVkXUoG69
August 16, 2017The NPPA found that while the average margin for the importer of knee implants varied between 42 and 65 percent, it rose to 89 to 200 percent for distributors depending on the type of implant. Average total trade margin varied between 182 and 269 percent by the time it's sold to the patient, the regulator said.
The regulator had capped prices of coronary stents in February, a move that was backed by Prime Minister Narendra Modi. Doctors, including leading cardiac surgeon Devi Prasad Shetty, chairman of Narayana Health, had warned that high-end cardiac stents won't be available in India due to the price caps and new stents won't be introduced in the country.
Also Read: Stent Price Cap Turns Away The Rich Patient On Whom Healthcare Survives: Devi Shetty
The regulator had cited “unethical markups” at each stage in the supply and “irrational” pricing for the caps on stents. Its reasons for price ceilings on knee implants are similar.
The NPPA cited “failed and exploitative market because of asymmetry between patient and healthcare delivery systems” as reasons to cap margins on knee implants. The regulator also emphasised the urgent need to impose price ceilings in NPPA “in view of extraordinary circumstances”.
The trade margin analysis in knee implants uploaded by NPPA is based on official Custom's data & data by Cos; analysis is accurate
August 10, 2017The regulator said all hospitals or any healthcare facility undertaking an orthopaedic knee transplant will have to adhere to the new pricing, in case they are selling it to patients directly. Hospitals should not solicit any patients to purchase knee implants in case they decide to procure such implants from third-party sources, the regulator added.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
